Works matching IS 20445385 AND DT 2020 AND VI 10 AND IP 1


Results: 13
    1

    Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41408-020-00357-4
    By:
    • Dimopoulos, Meletios A.;
    • Lonial, Sagar;
    • White, Darrell;
    • Moreau, Philippe;
    • Weisel, Katja;
    • San-Miguel, Jesus;
    • Shpilberg, Ofer;
    • Grosicki, Sebastian;
    • Špička, Ivan;
    • Walter-Croneck, Adam;
    • Magen, Hila;
    • Mateos, Maria-Victoria;
    • Belch, Andrew;
    • Reece, Donna;
    • Beksac, Meral;
    • Spencer, Andrew;
    • Oakervee, Heather;
    • Orlowski, Robert Z.;
    • Taniwaki, Masafumi;
    • Röllig, Christoph
    Publication type:
    Article
    3

    Correction: Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma.

    Published in:
    2020
    By:
    • Yellapantula, Venkata;
    • Hultcrantz, Malin;
    • Rustad, Even H.;
    • Wasserman, Ester;
    • Londono, Dory;
    • Cimera, Robert;
    • Ciardiello, Amanda;
    • Landau, Heather;
    • Akhlaghi, Theresia;
    • Mailankody, Sham;
    • Patel, Minal;
    • Medina-Martinez, Juan Santiago;
    • Ossa, Juan Esteban Arango;
    • Levine, Max Fine;
    • Bolli, Niccolo;
    • Maura, Francesco;
    • Dogan, Ahmet;
    • Papaemmanuil, Elli;
    • Zhang, Yanming;
    • Landgren, Ola
    Publication type:
    Correction Notice
    4

    SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41408-020-0277-6
    By:
    • Munshi, Manit;
    • Liu, Xia;
    • Chen, Jiaji G.;
    • Xu, Lian;
    • Tsakmaklis, Nickolas;
    • Demos, Maria G.;
    • Kofides, Amanda;
    • Guerrera, Maria Luisa;
    • Jimenez, Cristina;
    • Chan, Gloria G.;
    • Hunter, Zachary R.;
    • Palomba, M. Lia;
    • Argyropoulos, Kimon V.;
    • Meid, Kirsten;
    • Keezer, Andrew;
    • Gustine, Joshua;
    • Dubeau, Toni;
    • Castillo, Jorge J.;
    • Patterson, Christopher J.;
    • Wang, Jinhua
    Publication type:
    Article
    5
    6

    The significance of genetic mutations and their prognostic impact on patients with incidental finding of isolated del(20q) in bone marrow without morphologic evidence of a myeloid neoplasm.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41408-020-0275-8
    By:
    • Ravindran, Aishwarya;
    • He, Rong;
    • Ketterling, Rhett P.;
    • Jawad, Majd D.;
    • Chen, Dong;
    • Oliveira, Jennifer L.;
    • Nguyen, Phuong L.;
    • Viswanatha, David S.;
    • Reichard, Kaaren K.;
    • Hoyer, James D.;
    • Go, Ronald S.;
    • Shi, Min
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13

    Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysis.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41408-019-0266-9
    By:
    • Warsame, Rahma;
    • LaPlant, Betsy;
    • Kumar, Shaji K.;
    • Laumann, Kristina;
    • Perez Burbano, Gabriela;
    • Buadi, Francis K.;
    • Gertz, Morie A.;
    • Kyle, Robert A.;
    • Lacy, Martha Q.;
    • Dingli, David;
    • Leung, Nelson;
    • Hayman, Suzanne R.;
    • Kapoor, Prashant;
    • Hwa, Yi L.;
    • Fonder, Amie;
    • Hobbs, Miriam;
    • Gonsalves, Wilson I.;
    • Kourelis, Taxiarchis;
    • Lust, John;
    • Russell, Stephen J.
    Publication type:
    Article